Control (non-targeting) and tgs1 morpholino oligonucleotides (MOs) were purchased from (GeneTools, LLC) using the tgs1 XM_003197865.5 sequence as reference. MO sequences are reported in Supplementary Table S11. For TGS1 mRNA injection, human TGS1 cDNA (NM_001317902) was cloned into an N-terminal flag-pCS2 + mRNA expression vector. In vitro transcription of 5′-capped mRNAs was performed using the mMACHINE SP6 Transcription Kit (Ambion) following the manufacturer's protocol and as previously described in (33 (link),34 (link)). Embryos from TL/EK wild-type crossings were used to visualize the CaP-MN phenotype. Embryos were injected with the respective dose of MOs or mRNA in an aqueous solution containing 0.05% PhenolRed and 0.05% Rhodamine-Dextran (Sigma-Aldrich). At 6–7 h after injection, embryos were sorted according to homogeneity of the rhodamine fluorescence signal.